Author correction to ‘Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects’ [Acta Pharmaceutica Sinica B 13 (2023) 2138–2151]
Wei Wei(Nanchang University), Danqing Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingyang Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Tianyun Fan(Chinese Academy of Medical Sciences & Peking Union Medical College), Yinghong Li(Chongqing University of Posts and Telecommunications), Xixi Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Liping Zhao(Lanzhou University), Xican Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Wang(Fujian Normal University), Xintong Zhang(Shanxi Medical University), Yanxiang Wang(Shandong University), Yonghua Liu(Wenzhou Medical University), Hongbin Deng(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Ningbo University), Qingxuan Zeng(Chinese Academy of Medical Sciences & Peking Union Medical College), Yulong Shi(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 1
Related Papers
Enterotypes in the landscape of gut microbial community composition
|Nature Microbiology|2017|1.2k
Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice
|The ISME Journal|2009|1k
Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics
|Nucleic Acids Research|2019|830
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats
|Scientific Reports|2015|632
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics
|Nucleic Acids Research|2017|551